Join
Live feed
·
PRReleasevia Quantisnow
Biolase Inc. logo

BIOLASE DELIVERS 26% REVENUE GROWTH YEAR OVER YEAR IN THIRD QUARTER AND RAISES 2022 FULL YEAR REVENUE GUIDANCE

ByQuantisnow·Wall Street's wire, on your screen.
BIOL· Biolase Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BIOL (Biolase Inc.) and more on Quantisnow.